Klaria Pharma Financials
We recommend to make use of Klaria Pharma Holding fundamental analysis to find out if markets are presently mispricing the entity. Strictly speaking you can employ it to find out if Klaria Pharma Holding is indeed mispriced or if you can make any profits on it by purchasing it and then waiting for the market to recognize its mistake and reprise the security. We were able to interpolate and analyze data for thirty-one available fundamentals for Klaria Pharma, which can be compared to its peers in the industry.
Klaria |
Please note, the imprecision that can be found in Klaria Pharma's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Klaria Pharma Holding. Check Klaria Pharma's Beneish M Score to see the likelihood of Klaria Pharma's management manipulating its earnings.
Klaria Pharma Stock Summary
Klaria Pharma competes with Kancera AB, Lidds AB, Cantargia, and Xintela AB. Klaria Pharma Holding AB develops treatment methods in the therapeutic fields of migraine and pain related to cancer worldwide. Klaria Pharma Holding AB was founded in 2014 and is based in Uppsala, Sweden. Klaria Pharma is traded on Stockholm Stock Exchange in Sweden.| Instrument | Sweden Stock View All |
| Exchange | Stockholm Exchange |
| ISIN | SE0007280326 |
| Business Address | Virdings All 2, |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| Benchmark | Dow Jones Industrial |
| Website | www.klaria.com |
| Phone | 46 84 46 42 99 |
| Currency | SEK - Swedish Kronor |
You should never invest in Klaria Pharma without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Klaria Stock, because this is throwing your money away. Analyzing the key information contained in Klaria Pharma's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Klaria Pharma Key Financial Ratios
Klaria Pharma's financial ratios allow both analysts and investors to convert raw data from Klaria Pharma's financial statements into concise, actionable information that can be used to evaluate the performance of Klaria Pharma over time and compare it to other companies across industries.| Return On Equity | -0.88 | |||
| Return On Asset | -0.29 | |||
| Beta | 0.39 | |||
| Z Score | 22.8 |
Klaria Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Klaria Pharma's current stock value. Our valuation model uses many indicators to compare Klaria Pharma value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Klaria Pharma competition to find correlations between indicators driving Klaria Pharma's intrinsic value. More Info.Klaria Pharma Holding is currently regarded as number one stock in return on equity category among its peers. It also is currently regarded as number one stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Klaria Pharma's earnings, one of the primary drivers of an investment's value.Klaria Pharma Market Pulse
| Quote | 1.25 |
| Change(%) | 6.87 |
| Change | 0.90 |
| Open | 1.29 |
| Low | 1.17 |
| High | 1.29 |
| Volume | 393864 |
| Exchange | ST |
Klaria Pharma March 24, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Klaria Pharma help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Klaria Pharma Holding. We use our internally-developed statistical techniques to arrive at the intrinsic value of Klaria Pharma Holding based on widely used predictive technical indicators. In general, we focus on analyzing Klaria Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Klaria Pharma's daily price indicators and compare them against related drivers.
| Downside Deviation | 7.88 | |||
| Information Ratio | 0.175 | |||
| Maximum Drawdown | 140.42 | |||
| Value At Risk | (10.43) | |||
| Potential Upside | 21.33 |
Additional Tools for Klaria Stock Analysis
When running Klaria Pharma's price analysis, check to measure Klaria Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Klaria Pharma is operating at the current time. Most of Klaria Pharma's value examination focuses on studying past and present price action to predict the probability of Klaria Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Klaria Pharma's price. Additionally, you may evaluate how the addition of Klaria Pharma to your portfolios can decrease your overall portfolio volatility.